ABH Angel Biotech Holdings Contract with Renuron

Lots of money pouring into stem cell research so looks very good for this minnow

We are providing specialist solutions for cell based therapies e.g. cellular therapies and stem cells. The market for these therapies is expanding and Angel is in an excellent position to capitalize and become a market leader in providing such specialist services. We have a number of contracts moving into cGMP production where we have provided the client with a customized solution which meets their needs and accelerates their route to clinic. We expect to grow this part of our business significantly over the next few years, creating a differentiated offering for potential clients.





Published on 1/3/2007 in Nation, World » National Briefs

Washington — Two of the Democrats' top goals — a higher minimum wage and federal funding of embryonic stem cell research — enjoy broad public support as the party takes control of Congress for the first time in a dozen years. An overwhelming majority also supports making it easier for people to buy prescription drugs from other countries, an Associated Press-AOL poll said. Fully 80 percent of survey respondents favor raising the minimum wage. Nearly seven of 10 adults, 69 percent, favor the government taking steps to make it easier for people to buy prescription drugs from other countries. Importing prescription drugs to the United States is illegal. Some 56 percent of adults support easing restrictions on using federal money to pay for research on embryonic stem cells. The telephone survey of 1,004 adults was conducted Dec. 19-21 by Ipsos, an international public opinion research company. The margin of sampling error was plus or minus 3 percentage points.





New Jersey Gov. Signs Bill That Will Expand Stem Cell Research Facilities In The State
Main Category: Stem Cell Research News
Article Date: 02 Jan 2007 - 23:00 PST
| email this article | printer friendly | view or write opinions | Article Also Appears In
Women's Health / OBGYN



New Jersey Gov. Jon Corzine (D) on Wednesday signed into law a bill (S 1471) that will allow the state to borrow $270 million for the expansion of human embryonic stem cell research and facilities in the state, the New York Times reports (Jones, New York Times, 12/20). The measure -- which was approved earlier this month by state lawmakers and sponsored by Senate President Richard Codey (D) -- provides $50 million for a stem cell research center in Camden, $50 million for an adult stem cell research center in Newark and $150 million for a research facility in New Brunswick. The legislation also allocates $10 million to the Garden State Cancer Center in Belleville and $10 million to the Elie Katz Umbilical Cord Blood Program in Allendale (Kaiser Daily Women's Health Policy Report, 12/18). "This really puts New Jersey on the cutting-edge," Corzine said Wednesday, adding that additional funding is necessary because "[w]e don't want to just be part of the crowd. We want to lead the crowd" (Hester, AP/Long Island Newsday, 12/20). In addition, Corzine said that he supports a referendum that would ask voters to approve an additional $230 million for stem cell research grants (New York Times, 12/20). Officials, including Corzine, aim to put the referendum on the ballot by November 2007 (Fasbach, Herald News, 12/21).